Experts see tolebrutinib as part of a broader shift toward treatments that target the neurodegeneration in MS, not just its ...

Explore the increasing prevalence of Multiple Sclerosis (MS) in the 7MM with our comprehensive report. Understand global trends, risk factors, and demographics influencing the MS market through a ...

Fenebrutinib significantly reduced new lesions with active inflammation in people with relapsing MS in a Phase 2 trial.

Heidi Crayton, MD, and Maria Lopes, MD, discuss the impact of multiple sclerosis on patients, families, and caregivers, differentiate relapsing forms (relapsing-remitting and primary progressive ...

A team of scientists analyzed data from over a dozen studies involving more than 900 people with MS to research iron rim ...

DelveInsight’s, “Multiple Sclerosis Pipeline Insight 2025” report provides comprehensive insights about 75+ companies and 80+ ...

While multiple sclerosis can happen at any moment, Lindsey says it usually starts in young adults between their 20s and 40s. There are four disease courses of multiple sclerosis.

RRMS is the most common type of MS. Primary Progressive Multiple Sclerosis (PPMS)—PPMS means a person has symptoms that worsen over time without any remission period (a temporary decrease or ...

Multiple Sclerosis Types Though MS is highly unpredictable and varied, most people will initially experience episodes of flares, or exacerbations, followed by remission.